In the year ago, the registered Rs. For the nine -month period ended December 31, 2024, Rs. The company made a profit after the tax of Rs 67.79 crore.
Commenting on financial operations, CEO of DR Agarwal’s Health Care Limited DR Dr. Adil Agarwal said, “We have grown strong revenue and 26.3 percent in EBITDA. We have registered a strong growth in the steps of both patients and the number of surgery.”
“Our commitment to providing exceptional care with the investment of cutting Edge Technol in G, gives us a long -term success. When we maintain our way of growth, we are committed to delivering sustainable and steady growth in the coming quarters,” said Agarwal. , “Agarwal said. .
The total revenue increased to Rs. 443.43 crore, which was registered in the corresponding quarter of the last financial year. 344.69 crore.
For the nine -month period ended December 31, 2024, the unified total income was Rs. 1,281.37 crore increased, compared to 1,007.38 crore recorded in the year ago.
The company added 42 new features during the April-December 2024 period, of which 35 new facilities were established while seven were received.
After the quarter ended December 31, 2024, DR Agarwal’s Health Care Limited said that it had completed its initial public offer in which each of the Rs. With a face value of 1, 74,62,626266 equity shares are included and offers sales of 6,78. R1,84 Re Each’s Face Value Equity Shares. These shares were offered at an issue of Rs 402 per share, including 15,78,399 equal Y shares reserved for eligible employees.
The company has paid Rs. 300 crore including a total of Rs. 0,7 crore were collected and the company’s equity shares were listed on BSE Limited and the National Stock Exchange from February 4 after February 4.
(Now you can subscribe to our Etmarkets WhatsApp channel)